Product Details:
| Minimum Order Quantity | 10 Strip |
| Strength | 200 mg |
| Brand | Macgest SR 200 |
| Packaging Size | 10x10 |
| Drug Strength | 100/200 |
| Dose | once a day or twice a day |
| Packaging Type | Strip |
| Manufacturer | Macleods |
Additional Information:
Product Details:
| Strength | 5000iu |
| Dose | consult doctor |
| Packaging Size | 1 ml (10 units) |
| Packaging Type | Vial |
| Drug Strength | 1 ml |
Product Details:
| Minimum Order Quantity | 10 unit |
| Strength | 10000iu |
| Brand | HUCOG-10000 HP |
| Manufacturer | BHARAT SERUMES AND VACCINES LIMITED |
| Packaging Size | 1X10 ML |
| Dose Strength | 10000 iu |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Strip |
| Strength | 25 mg |
| Product Type | API |
| Dose Strength | 25 mg |
| Packaging Type | Strip |
| Packaging Size | 10x30 |
| Country of Origin | Made in India |
| Brand | Fertyl-M Tablet |
| composition | Clomifene 25 mg tablet |
Clomiphene 25 mg (also spelled Clomifene) is a medication primarily used to induce ovulation in women who are having difficulty conceiving due to ovulatory dysfunction, such as in Polycystic Ovary Syndrome (PCOS). It is also used off-label in men with low testosterone to stimulate natural hormone production.
🔬 What is Clomiphene?Drug class: Selective Estrogen Receptor Modulator (SERM)
Brand names: Clomid, Serophene, Fertomid, Clomibeg, Clofert, etc.
Formulation: Usually available in 25 mg, 50 mg, and 100 mg tablets.
Clomiphene blocks estrogen receptors in the brain (specifically the hypothalamus). This causes the body to believe that estrogen levels are low, which:
Increases GnRH (Gonadotropin-releasing hormone) secretion.
Stimulates the pituitary gland to release FSH (Follicle-stimulating hormone) and LH (Luteinizing hormone).
These hormones then trigger ovulation in women or testosterone production in men.
Ovulation induction in women with infertility
PCOS (Polycystic Ovary Syndrome)
Luteal phase defect
Unexplained infertility
Amenorrhea (absence of menstruation)
Hypogonadism (low testosterone)
Male infertility (to increase sperm count and motility)
Secondary infertility due to anabolic steroid use (to restart natural testosterone production)
25–50 mg once daily for 5 days, starting on Day 2–5 of the menstrual cycle.
Dose may be increased up to 100–150 mg/day, if no ovulation occurs.
Usually tried for up to 6 cycles.
25–50 mg every other day or daily, depending on condition and lab results.
Used for several months with periodic testosterone and sperm count checks.
In women: Ovulation usually occurs 5–10 days after the last dose.
In men: May take 4–6 weeks or more for testosterone and sperm count to improve.
Hot flashes
Mood swings
Breast tenderness
Bloating
Nausea
Headache
Ovarian enlargement
Ovarian Hyperstimulation Syndrome (OHSS)
Multiple pregnancy (twins or more)
Blurred vision (reversible)
Acne
Mood changes
Increased libido
Gynecomastia (rare)
Visual disturbances (rare)
Additional Information:
Product Details:
| Minimum Order Quantity | 3 Pack |
| Strength | 10000iu |
| Brand | HUCOG |
| Manufacturer | BHARAT SERUMS AND VACCINES LIMITED |
| Packaging Size | 1 ML OF GLASS BOTTLE |
| Dose Strength | 10000 |
| PACKAGING TYPE | VIAL |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Strip |
| Strength | 0.5 mg |
| Packaging Size | 4 Tablets |
| Brand | Cabernol-0.5 mg tablet |
| Manufacturer | Knoll |
| Composition | Cabergoline 0.5 mg tablet |
Cabergoline 0.5 mg tablet (often misspelled as "Cebergoline") is a dopamine receptor agonist medication used primarily to treat hyperprolactinemia (high levels of the hormone prolactin). It is also used in certain Parkinson’s disease cases, and off-label for hormone balance, infertility, and bodybuilding PCT (Post Cycle Therapy).
Cabergoline is a long-acting dopamine D2 receptor agonist.
It inhibits prolactin secretion by acting on the pituitary gland.
Brand names: Dostinex, Cabgolin, Cabaser, Caberdost, Caberlin.
Each tablet contains 0.5 mg of cabergoline.
Taken orally, usually once or twice per week (not daily).
Sold in blister strips or bottles (0.5 mg is the most common dose).
| Condition | Effect |
|---|---|
| Hyperprolactinemia | Lowers high prolactin levels |
| Prolactinomas | Shrinks prolactin-secreting pituitary tumors |
| Amenorrhea (no periods) | Helps restore normal menstrual cycles |
| Galactorrhea | Stops abnormal breast milk production |
| Infertility (male & female) | Helps regulate ovulation and testosterone |
| Parkinson’s disease | Used in some cases (less common now) |
Cabergoline binds dopamine D2 receptors in the pituitary.
Dopamine naturally inhibits prolactin, so cabergoline enhances this effect.
Reduces prolactin secretion, correcting hormonal imbalance.
In bodybuilding or hormone therapy, it's used to:
Prevent or treat prolactin-related side effects (e.g., from steroids like trenbolone or nandrolone).
Support testosterone recovery during PCT (Post-Cycle Therapy).
| Condition | Usual Dose |
|---|---|
| Hyperprolactinemia | 0.25 to 0.5 mg twice weekly (max 1 mg 2×/week) |
| Prolactinoma | Start 0.5 mg/week → gradually increase |
| Bodybuilding PCT | 0.25–0.5 mg 2×/week, short term (off-label) |
🔹 Not taken daily — due to long half-life (~65 hours)
🔹 Always take after food to reduce nausea
Onset: Within hours
Prolactin lowering effect: Peaks within 3–6 days
Duration: Lasts up to 7–14 days per dose
Heart valve disorders
Uncontrolled hypertension
History of pulmonary fibrosis
Severe liver disease
Pregnant/breastfeeding (only under specialist advice)
Macrolide antibiotics (like erythromycin): may increase blood levels of cabergoline
Antipsychotics: may reduce effectiveness
Other dopamine agonists: increase side effect risk
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Box |
| Packaging Size | 7 Suppository |
| Strength | 100 mg/100 mg |
| Packaging Type | Box |
| Form | Capsule |
| Brand | CLINGEN FORTE VEGINAL CAPSULE |
| Manufactured by | ARISTO |
Clindamycin: Lincosamide antibiotic – active against anaerobic bacteria.
Clotrimazole: Imidazole antifungal – broad spectrum against Candida and other fungi.
Tinidazole: Nitroimidazole antiprotozoal & antibacterial – active against Trichomonas and anaerobic bacteria.
This triple-drug combination is designed to treat mixed vaginal infections, where bacteria, fungi, and protozoa may all contribute to symptoms.
Mechanism of ActionClindamycin (100 mg)
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
Effective against anaerobic bacteria commonly involved in bacterial vaginosis.
Clotrimazole (100 mg)
Inhibits synthesis of ergosterol (a key component of fungal cell membranes).
Causes membrane damage and leakage → fungal cell death.
Effective against Candida albicans and other yeasts.
Tinidazole (100 mg)
Reduces intracellular nitro groups to form toxic free radicals that damage parasite DNA.
Effective against Trichomonas vaginalis (trichomoniasis) and anaerobic bacteria.
This combination is mainly prescribed for:
Mixed vaginal infections, especially when symptoms may be caused by:
Bacterial vaginosis (Gardnerella, Mobiluncus, anaerobes)
Candidiasis (Candida albicans and related fungi)
Trichomoniasis (Trichomonas vaginalis)
Non-specific vaginitis where cause is uncertain or multiple organisms are suspected.
Used in women with recurring or resistant vaginal infections.
Commonly used as a vaginal capsule/pessary: Inserted deep into the vagina at bedtime.
Typical regimen: 1 capsule once daily for 7 days (may vary depending on doctor’s advice).
Oral forms (less common in this combination) may also be used for systemic therapy.
Clindamycin → Anaerobic bacteria
Clotrimazole → Yeast/fungal infections
Tinidazole → Protozoa + anaerobic bacteria
👉 This makes the combination broad-spectrum, covering almost all common causes of vaginal discharge.
Most are local and mild:
Vaginal irritation, burning, or itching
Unusual vaginal discharge (as infection clears)
Abdominal cramps
Nausea (if some absorption occurs)
Headache or metallic taste (from tinidazole)
Rare: diarrhea, allergic reactions, superinfection with resistant organisms
Pregnancy: Usually avoided in the first trimester; can be used with caution later if prescribed.
Breastfeeding: Tinidazole may pass into milk; short-term therapy may be acceptable but requires medical advice.
Alcohol: Avoid during and for 72 hours after tinidazole use → can cause disulfiram-like reaction (nausea, flushing, vomiting, palpitations).
Should not be used during menstruation (best results when used after period).
Avoid sexual intercourse during treatment (or use condoms) to prevent reinfection and ensure effectiveness.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Piece |
| Strength | 150 IU |
| Formulation | Highly Purified (HP) |
| Brand Name | Puregraf |
| Dosage Form | Vial (Powder for Reconstitution) |
| Route of Administration | Intramuscular (IM) |
| Pack Size | 1 Vial |
| Storage Requirements | Refrigerated (2degC to 8degC) |
PUREGRAF 150 mg Injection
Generic Name: Human Menopausal Gonadotropin (HMG)
Strength: 150 IU (contains both FSH – Follicle Stimulating Hormone & LH – Luteinizing Hormone activity)
Form: Injection (for subcutaneous or intramuscular use)
Category: Gonadotropin / Fertility medicine
Female Infertility Treatment
Used in women who do not ovulate (anovulation) due to low hormone levels.
Stimulates growth and maturation of ovarian follicles.
Commonly given in Assisted Reproductive Techniques (ART) like IVF (In-vitro Fertilization) and IUI (Intrauterine Insemination).
Helps induce ovulation in women resistant to clomiphene citrate.
Male Infertility Treatment
Used in men with hypogonadotropic hypogonadism (low FSH/LH).
Promotes spermatogenesis (sperm production) when used along with hCG (Human Chorionic Gonadotropin).
Other Hormonal Disorders
Sometimes used in controlled ovarian hyperstimulation protocols.
FSH component: Stimulates ovaries in women → follicle growth & egg development. In men → supports sperm formation.
LH component: Stimulates estrogen production in women and testosterone production in men.
Women: Usually started at 75–150 IU daily for 5–12 days (adjusted by doctor based on ovarian response via ultrasound and hormone tests).
Men: Often 75–150 IU 2–3 times per week for several months, usually in combination with hCG.
Given intramuscularly (IM) or subcutaneously (SC).
(Exact dose, duration, and monitoring must be strictly supervised by a fertility specialist.)
Side EffectsCommon in women:
Abdominal bloating, pelvic pain
Headache, mood swings, breast tenderness
Injection site pain/redness
Serious risks:
Ovarian Hyperstimulation Syndrome (OHSS): Enlarged ovaries, fluid in abdomen/chest, weight gain, shortness of breath.
Multiple pregnancies (twins/triplets)
Rare blood clot risk
In men:
Gynecomastia (breast enlargement)
Acne, mood changes
Injection site reactions
Should be used only under supervision of a fertility specialist.
Requires regular ultrasound monitoring and hormone level tests.
Not suitable for women with ovarian cysts (not due to PCOS), unexplained vaginal bleeding, hormone-sensitive tumors, or ovarian failure.
Additional Information: